Extension of antimicrobial treatment in patients with left-sided native valve endocarditis based on elevated C-reactive protein values

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 26, Issue 8, 2007, Pages 587-590

  Verhagen, D W M ^a   Hermanides, J ^a   Korevaar, J C ^a   Bossuyt, P M M ^a   Van Den Brink, R B A ^a   Speelman, P ^a   Van Der Meer, J T M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; ENDOCARDITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DRUG ADMINISTRATION SCHEDULE; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34547124041     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-007-0319-z     Document Type: Article

References (15)

1. Wilson WR, Karchmer AW, Dajani AS et al (1995) Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 274:1706-1713
2. Elliot TS, Foweraker J, Gould FK, Perry JD, Sandoe JA (2004) Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 54:971-981
3. van der Meer JT, Thompson J, Valkenburg HA, Michel MF (1992) Epidemiology of bacterial endocarditis in the Netherlands I. Patients characteristics. Arch Int Med 152:1863-1868
4. Durack DT, Lukes AS, Bright DK (1994) New criteria for diagnosis of infective endocarditis: utilisation of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96:200-209
5. Hellgren U, Julander I (1986) Are white blood cell count, platelet count, erythrocyte sedimentation rate and C-reactive protein useful in the diagnosis of septicaemia and endocarditis? Scand J Infect Dis 18:487-488
6. Hogevik H, Olaison L, Andersson R, Alestig K (1997) C-reactive protein is more sensitive than erythrocyte sedimentation rate for diagnosis of infective endocarditis. Infection 25:82-85
7. Lindback S, Hellgren U, Julander I, Hansson LO (1989) The value of C-reactive protein as a marker of bacterial infection in patients with septicaemia/endocarditis and influenza. Scand J Infect Dis 21:543-549
8. Mueller C, Huber P, Laifer G, Mueller B, Perruchoud AP (2004) Procalcitonin and the early diagnosis of infective endocarditis. Circulation 109:1707-1710
9. Koegelenberg CF, Doubell AF, Orth H, Reuter H (2004) Infective endocarditis: improving the diagnostic yield. Cardiovasc J S Afr 15:14
10. Alter P, Hoeschen J, Ritter M, Maisch B (2002) Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves. Am J Cardiol 89:1400-1404
11. Olaison L, Hogevik H, Alestig K (1997) Fever, C-reactive protein and other acute-phase reactants during treatment of infective endocarditis. Arch Intern Med 157:885-892
12. Kocazeybek B, Kucukoglu S, Oner YA (2003) Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy 49:76-84
13. McCartney AC, Orange GV, Pringle SD, Wills G (1988) Serum C reactive protein in infective endocarditis. J Clin Pathol 41:44-48
14. Heiro M, Helenius H, Sundell J et al (2005) Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J 26:1873-1881
15. Osler W (1885) Gulstonian lectures on malignant endocarditis. Lancet 1:415-418